Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F22%3A00083368" target="_blank" >RIV/00023001:_____/22:00083368 - isvavai.cz</a>
Result on the web
<a href="https://www.degruyter.com/document/doi/10.1515/tnsci-2022-0249/html" target="_blank" >https://www.degruyter.com/document/doi/10.1515/tnsci-2022-0249/html</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1515/tnsci-2022-0249" target="_blank" >10.1515/tnsci-2022-0249</a>
Alternative languages
Result language
angličtina
Original language name
Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia
Original language description
Introduction Esophageal achalasia is a primary motility disorder. Although the exact pathogenesis is unknown, autoimmune, and neurodegenerative processes seem to be involved similarly to neurodegenerative and/or demyelinating disorders (NDDs). We hypothesized that the prevalence of NDD may be higher among patients with achalasia and vice versa as the background pathogenetic mechanisms are similar. Methods This was a prospective, comparative questionnaire-based study. Patients with achalasia and patients with NDD were enrolled. Selected patients with achalasia were thoroughly examined by a neurologist and selected patients with NDD were examined by a gastroenterologist to confirm or rule out NDD or achalasia. We assessed the prevalence of both achalasia and NDD and compared them with their prevalence in general population. Results A total of 150 patients with achalasia and 112 patients with NDD were enrolled. We observed an increased prevalence of NDD among patients with achalasia (6.0% (9/150); 95% CI (confidence interval): 3.1-11.2%) as compared to the estimated 2.0% prevalence in general population (p = 0.003). Although 32 out of 112 patients (28.6%) with NDD reported dysphagia, we did not observe significantly increased prevalence of achalasia in these patients (1.8% (2/112) vs 0.8% in general population, p = 0.226). Conclusion The prevalence of NDD was significantly higher among patients with achalasia (6.0%) compared to general population (2.0%), suggesting an association of these disorders. Large-volume studies are necessary to confirm this finding.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30219 - Gastroenterology and hepatology
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Translational neuroscience
ISSN
2081-3856
e-ISSN
2081-6936
Volume of the periodical
13
Issue of the periodical within the volume
1
Country of publishing house
PL - POLAND
Number of pages
8
Pages from-to
361-368
UT code for WoS article
000865543600001
EID of the result in the Scopus database
2-s2.0-85140650729